Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 1P-LSD

1P-LSD in United Kingdom: not individually verified

Not individually verified

We have not confirmed that 1P-LSD specifically is scheduled in United Kingdom, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed whether it is a Class A drug. 1P-LSD, 1-propionyl-lysergic acid diethylamide, is not named in Schedule 2 to the Misuse of Drugs Act 1971 as in force on 2 October 2026. The entry that could reach it is «Lysergide and otherN-alkyl derivatives of lysergamide.» in Part I, paragraph 1(a), and the text does not settle whether a lysergamide that is N-alkylated on the amide nitrogen and also carries a propionyl group on the indole nitrogen is one of those derivatives. Paragraph 3, the ester and ether paragraph, does not help, because the propionyl group forms an amide, not an ester. S.I. 2014/3271 named ALD-52, the 1-acetyl homologue, as a separate Class A entry from 7 January 2015, which suggests the lysergide entry was not relied on for 1-acyl compounds, but that is an inference from the drafting and not a statement in the text. If it is not a controlled drug, it is a psychoactive substance under the Psychoactive Substances Act 2016, whose Schedule 1 does not exempt it. The text read is the legislation.gov.uk revised text of the Act as in force on 2 October 2026, whose Schedule 2 page states «There are currently no known outstanding effects for the Misuse of Drugs Act 1971, SCHEDULE 2.» The last amendment that text incorporates is the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2024, S.I. 2024/1361, in force 15 January 2025; a title search of the same site for 2025 and 2026 found no later amending Order, and the draft Misuse of Drugs Act 1971 (Amendment) Order 2026 is marked «This is a draft item of legislation and has not yet been made as a UK Statutory Instrument.» Schedule 2 moves by Order in Council under section 2(2), which reads «Her Majesty may by Order in Council make such amendments in Schedule 2 to this Act as may be requisite for the purpose of adding any substance or product to, or removing any substance or product from, any of Parts I to III of that Schedule», so this does not rule out a later amendment. Section 2(1)(a) also makes a controlled drug of anything specified «in a temporary class drug order as a drug subject to temporary control (but this is subject to section 2A(6));» the only such Order found in force, the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2026, S.I. 2026/613, in force from 11 June 2026 for one year, lists seven synthetic opioids of the orphine type, from cychlorphine to 5,6-dichlorobrorphine, and this row is not among them.

Confirm directly with United Kingdom’s national drug authority or your own embassy before you rely on anything.

What United Kingdom HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.